A detailed history of Mc Adam, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Mc Adam, LLC holds 11,833 shares of LQDA stock, worth $130,281. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,833
Previous 12,034 1.67%
Holding current value
$130,281
Previous $144,000 18.06%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$8.9 - $14.11 $1,788 - $2,836
-201 Reduced 1.67%
11,833 $118,000
Q2 2024

Jul 24, 2024

SELL
$11.96 - $15.71 $17,425 - $22,889
-1,457 Reduced 10.8%
12,034 $144,000
Q1 2024

Apr 23, 2024

SELL
$11.35 - $16.73 $8,546 - $12,597
-753 Reduced 5.29%
13,491 $198,000
Q4 2023

Feb 05, 2024

SELL
$5.77 - $12.19 $213,911 - $451,919
-37,073 Reduced 72.24%
14,244 $171,000
Q3 2023

Oct 31, 2023

BUY
$6.27 - $8.15 $321,757 - $418,233
51,317 New
51,317 $325,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Mc Adam, LLC Portfolio

Follow Mc Adam, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.